Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours
- PMID: 1552940
- DOI: 10.1038/356215a0
Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours
Abstract
Mutations in the p53 tumour-suppressor gene are the most frequently observed genetic lesions in human cancers. To investigate the role of the p53 gene in mammalian development and tumorigenesis, a null mutation was introduced into the gene by homologous recombination in murine embryonic stem cells. Mice homozygous for the null allele appear normal but are prone to the spontaneous development of a variety of neoplasms by 6 months of age. These observations indicate that a normal p53 gene is dispensable for embryonic development, that its absence predisposes the animal to neoplastic disease, and that an oncogenic mutant form of p53 is not obligatory for the genesis of many types of tumours.
Similar articles
-
A mutant p53 transgene accelerates tumour development in heterozygous but not nullizygous p53-deficient mice.Nat Genet. 1995 Mar;9(3):305-11. doi: 10.1038/ng0395-305. Nat Genet. 1995. PMID: 7773294
-
Gene replacement of the p53 gene with the lacZ gene in mouse embryonic stem cells and mice by using two steps of homologous recombination.Biochem Biophys Res Commun. 1994 Jul 29;202(2):830-7. doi: 10.1006/bbrc.1994.2005. Biochem Biophys Res Commun. 1994. PMID: 8048955
-
Spontaneous and carcinogen-induced tumorigenesis in p53-deficient mice.Nat Genet. 1993 Nov;5(3):225-9. doi: 10.1038/ng1193-225. Nat Genet. 1993. PMID: 8275085
-
Murine models of neoplasia: functional analysis of the tumour suppressor genes Rb-1 and p53.Cancer Metastasis Rev. 1995 Jun;14(2):125-48. doi: 10.1007/BF00665796. Cancer Metastasis Rev. 1995. PMID: 7554030 Review.
-
Transgenic mouse models for tumour-suppressor genes.J Intern Med. 1995 Sep;238(3):233-8. doi: 10.1111/j.1365-2796.1995.tb00928.x. J Intern Med. 1995. PMID: 7673852 Review.
Cited by
-
Breathing new insights into the role of mutant p53 in lung cancer.Oncogene. 2024 Nov 20. doi: 10.1038/s41388-024-03219-6. Online ahead of print. Oncogene. 2024. PMID: 39567755 Review.
-
Myeloid Mir34a suppresses colitis-associated colon cancer: characterization of mediators by single-cell RNA sequencing.Cell Death Differ. 2024 Oct 18. doi: 10.1038/s41418-024-01380-9. Online ahead of print. Cell Death Differ. 2024. PMID: 39425000
-
Radiation-Associated Angiosarcoma of the Breast: The State of the Art of a Rare and Aggressive Disease.J Pers Med. 2024 Aug 14;14(8):859. doi: 10.3390/jpm14080859. J Pers Med. 2024. PMID: 39202050 Free PMC article. Review.
-
Genetic Screen in a Preclinical Model of Sarcoma Development Defines Drivers and Therapeutic Vulnerabilities.Clin Cancer Res. 2024 Nov 1;30(21):4957-4973. doi: 10.1158/1078-0432.CCR-24-1238. Clin Cancer Res. 2024. PMID: 39177582
-
Mouse models to investigate in situ cell fate decisions induced by p53.EMBO J. 2024 Oct;43(19):4406-4436. doi: 10.1038/s44318-024-00189-z. Epub 2024 Aug 19. EMBO J. 2024. PMID: 39160273 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Research Materials
Miscellaneous
